Waters Corporation WAT
433.54
3.24
0.75%
as of 25 Sep
- Market cap
- $42.3B
- P/E
- 108×
Follow WAT
Indexes
indicate stock being part of an index,
Insider Buys
alert about insiders buying in the last 12 month
Waters Corporation (WAT) Operating cash flow
Waters Corporation's operating cash flow for fiscal 2025 was $652.6M, down 14.4% from $762.1M in fiscal 2024. Over the twelve months to 30 June 2026 it was $549.6M. Over the past ten years it has ranged from $573.2M (fiscal 2015) to $790.5M (fiscal 2020); the current reading is higher than 64% of that period. Waters Corporation ranks 15th of 52 Diagnostics & Research companies by operating cash flow.
Operating cash flow, annual
Annual
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $652.6M | (14.38%) |
| FY2024 | $762.1M | 26.43% |
| FY2023 | $602.8M | (1.45%) |
| FY2022 | $611.7M | (18.15%) |
| FY2021 | $747.3M | (5.47%) |
| FY2020 | $790.5M | 22.92% |
| FY2019 | $643.1M | 6.39% |
| FY2018 | $604.4M | (13.36%) |
| FY2017 | $697.6M | 8.51% |
| FY2016 | $642.9M | 12.15% |
Quarterly
| Period | Operating cash flow | Change |
|---|---|---|
| Jun 2026 | $201.0M | — |
| Mar 2026 | −$3.0M | — |
| Dec 2025 | $164.6M | (12.00%) |
| Sep 2025 | $187.0M | 356.10% |
| 42 more quarters | Free account |
Against its own ten years
Low $573.2M
High $790.5M
Ten-year median
$643.1M
Current reading's percentile
64
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| IQV IQVIA Holdings Inc. compare | $2.8B |
| DGX Quest Diagnostics Incorporated compare | $1.9B |
| A Agilent Technologies, Inc. compare | $1.6B |
| IDXX IDEXX Laboratories, Inc. compare | $1.4B |
| ILMN Illumina, Inc. compare | $1.1B |
| MTD Mettler-Toledo International, Inc. compare | $975.2M |
| WAT Waters Corporation | $549.6M |
| NTRA Natera, Inc. compare | $228.2M |
| GH Guardant Health, Inc. compare | −$185.2M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on WAT
- Revenue
- Net income
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement